198 related articles for article (PubMed ID: 14504283)
1. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.
Sherbet DP; Tiosano D; Kwist KM; Hochberg Z; Auchus RJ
J Biol Chem; 2003 Dec; 278(49):48563-9. PubMed ID: 14504283
[TBL] [Abstract][Full Text] [Related]
2. Modulation of 17alpha-hydroxylase/17,20-lyase activity of guinea pig cytochrome P450c17 by site-directed mutagenesis.
Beaudoin C; Lavallée B; Tremblay Y; Hum DW; Breton R; de Launoit Y; Bélanger A
DNA Cell Biol; 1998 Aug; 17(8):707-15. PubMed ID: 9726253
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.
Van Den Akker EL; Koper JW; Boehmer AL; Themmen AP; Verhoef-Post M; Timmerman MA; Otten BJ; Drop SL; De Jong FH
J Clin Endocrinol Metab; 2002 Dec; 87(12):5714-21. PubMed ID: 12466376
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the adrenal cytochrome P450C17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosynthesis.
Cloutier M; Fleury A; Courtemanche J; Ducharme L; Mason JI; Lehoux JG
DNA Cell Biol; 1997 Mar; 16(3):357-68. PubMed ID: 9115645
[TBL] [Abstract][Full Text] [Related]
5. Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity.
Tiosano D; Knopf C; Koren I; Levanon N; Hartmann MF; Hochberg Z; Wudy SA
Eur J Endocrinol; 2008 Mar; 158(3):385-92. PubMed ID: 18299473
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
[TBL] [Abstract][Full Text] [Related]
7. Chimerogenesis in estimation of specificity and pathway directions for cytochrome p45017alpha catalyzed reactions.
Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2004 Apr; 69(4):364-75. PubMed ID: 15170370
[TBL] [Abstract][Full Text] [Related]
8. Baboon cytochrome P450 17alpha-hydroxylase/17,20-lyase (CYP17).
Swart AC; Kolar NW; Lombard N; Mason JI; Swart P
Eur J Biochem; 2002 Nov; 269(22):5608-16. PubMed ID: 12423360
[TBL] [Abstract][Full Text] [Related]
9. Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling.
Patocs A; Liko I; Varga I; Gergics P; Boros A; Futo L; Kun I; Bertalan R; Toth S; Pazmany T; Toth M; Szücs N; Horanyi J; Glaz E; Racz K
J Steroid Biochem Mol Biol; 2005 Nov; 97(3):257-65. PubMed ID: 16176874
[TBL] [Abstract][Full Text] [Related]
10. Ovine steroid 17alpha-hydroxylase cytochrome P450: characteristics of the hydroxylase and lyase activities of the adrenal cortex enzyme.
Swart P; Lombard N; Swart AC; van der Merwe T; Murry BA; Nicol M; Ian Mason J
Arch Biochem Biophys; 2003 Jan; 409(1):145-52. PubMed ID: 12464253
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of isolated 17,20 lyase deficiency.
Miller WL; Geller DH; Auchus RJ
Endocr Res; 1998; 24(3-4):817-25. PubMed ID: 9888582
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
Gupta MK; Geller DH; Auchus RJ
J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
[TBL] [Abstract][Full Text] [Related]
13. CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
van Rooyen D; Yadav R; Scott EE; Swart AC
J Steroid Biochem Mol Biol; 2020 May; 199():105614. PubMed ID: 32007561
[TBL] [Abstract][Full Text] [Related]
14. Active site proton delivery and the lyase activity of human CYP17A1.
Khatri Y; Gregory MC; Grinkova YV; Denisov IG; Sligar SG
Biochem Biophys Res Commun; 2014 Jan; 443(1):179-84. PubMed ID: 24299954
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the Clinically Relevant E305G Mutation in Human P450 CYP17A1.
Liu Y; Grinkova Y; Gregory MC; Denisov IG; Kincaid JR; Sligar SG
Biochemistry; 2021 Nov; 60(43):3262-3271. PubMed ID: 34662099
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid residue, Ala 105, confers 16alpha-hydroxylase activity to human cytochrome P450 17alpha-hydroxylase/17,20 lyase.
Swart AC; Storbeck KH; Swart P
J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):112-20. PubMed ID: 20043997
[TBL] [Abstract][Full Text] [Related]
17. Towards a unifying mechanism for CYP17 mutations that cause isolated 17,20-lyase deficiency.
Auchus RJ; Gupta MK
Endocr Res; 2002 Nov; 28(4):443-7. PubMed ID: 12530647
[TBL] [Abstract][Full Text] [Related]
18. Combined 17alpha-Hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene.
Di Cerbo A; Biason-Lauber A; Savino M; Piemontese MR; Di Giorgio A; Perona M; Savoia A
J Clin Endocrinol Metab; 2002 Feb; 87(2):898-905. PubMed ID: 11836339
[TBL] [Abstract][Full Text] [Related]
19. A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency.
Brooke AM; Taylor NF; Shepherd JH; Gore ME; Ahmad T; Lin L; Rumsby G; Papari-Zareei M; Auchus RJ; Achermann JC; Monson JP
J Clin Endocrinol Metab; 2006 Jun; 91(6):2428-31. PubMed ID: 16569739
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of 17α-hydroxylase/17,20-lyase deficiency.
Yanase T; Imai T; Simpson ER; Waterman MR
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):973-9. PubMed ID: 22217842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
